PitchBook for due diligenceRequest a free trial
Pitches are biased. PitchBook isn‘t. Our data not only gives you details that enhance pitches, but it also puts companies, funds and financial sponsors into perspective. Determine what opportunities to pursue and who to work with based on the big picture, not a snapshot.
Evaluate companies‘ financing histories, series terms, cap tables, revenue figures, executives, investors and more to determine which targets are worth pursuing.
Compare a potential investment to similar companies and industry trends to get a better idea of the target‘s growth and trajectory.
Benchmark a fund you‘ve been pitched against a peer group you choose (based on underlying factors like portfolio construction and industry focus) to get a more objective view of a general partner‘s performance and place in the landscape.
See which fund managers consistently drove returns (or got lucky once) with insight into the deals they‘ve led and how those transactions affected fund performance.
Determine if your company should take financing from a financial sponsor based on how well the firm‘s investments are performing.
With access to clinical trial insights—such as phase, enrollment numbers, status and more—alongside our industry-leading financial data, investors can isolate biotech and pharma prospects with the highest chance of success, assess the value of opportunities and better mitigate risk—all with one easy-to-use platform.
Plus, with robust company patent data at your fingertips, you can spend less time scouring search engines and more time gaining insight into a company’s technology assets. Explore the underlying filing documents of active, pending and expired patents from every major North American and European patent authority, as well as the World Intellectual Property Organization and more.